Self-perceived versus physician documented adverse events in patients with multiple sclerosis REGIMS-a pharmacovigilance registry for patients with multiple sclerosis in Germany-Reference-Cited by-同舟云学术

Self-perceived versus physician documented adverse events in patients with multiple sclerosis REGIMS-a pharmacovigilance registry for patients with multiple sclerosis in Germany

Published:2022-03 Issue: Volume:59 Page:103684
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Moeller Sarah Noelle^ORCID,Simbrich Alexandra

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,General Medicine

Reference51 articles.

1. Agbabiaka T.B., Savovic J., Ernst E. Methods for causality assessment of adverse drug reactions: a systematic review. New Zealand; 2008.

2. Aubagio: European public assessment report (EPAR) - product information; first published: 2013 Last updated: 2019 [cited 2021 Jun 29]. Available from: URL: https://www.ema.europa.eu/en/documents/product-information/aubagio-epar-product-information_en.pdf.

3. Avonex: European public assessment report (EPAR) - product Information; first published: 2019 Last updated: 2019 [cited 2021 Jun 29]. Available from: URL: https://www.ema.europa.eu/en/documents/product-information/avonex-epar-product-information_en.pdf.

4. Bekanntmachung zur Anzeige von Nebenwirkungen und Arzneimittelmissbrauch nach § 63b Absatz 1 bis 9 des Arzneimittelgesetzes (AMG); 2010 [cited 2021 Jun 29]. Available from: URL: https://www.pei.de/SharedDocs/Downloads/DE/newsroom/bundesanzeiger/zulassungen/2010/01-2010-zul-banz-pharmvig-6.pdf;jsessionid=780F3474AB7386774724AC8ADC3C69ED.2_cid344?__blob=publicationFile&v=2.

5. Brief communication: better ways to question patients about adverse medical events: a randomized, controlled trial;Bent;Ann. Intern. Med.,2006